Alpha-2 adrenergic and opioid receptor-mediated gastroprotection

被引:42
|
作者
Gyires, K [1 ]
Müllner, K [1 ]
Fürst, S [1 ]
Rónai, AZ [1 ]
机构
[1] Semmelweis Univ, Fac Med, Dept Pharmacol & Pharmacotherapy, H-1089 Budapest, Hungary
关键词
gastroprotection; clonidine; alpha-2B adrenoceptors; opioid receptors;
D O I
10.1016/S0928-4257(00)00151-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Clonidine inhibited the development of gastric mucosal lesions induced by either acidified ethanol or indomethacin. The ED50 values were: 7.1 and 5.2 mu g.kg(-1) orally, respectively. The gastroprotective effect was antagonised by the pre-synaptic alpha-2 antagonist, yohimbine, the more selective alpha-2 antagonist Ch-38083 and the pre-synaptic alpha-2B antagonist prazosin. Moreover, the non-selective opioid receptor antagonist naloxone, the delta receptor selective naltrindole also reversed the clonidine-induced mucosal protective action. Clonidine was also effective following intracerebroventricular administration with the ED50 of 37 ng/rat against ethanol-induced mucosal damage. Our results suggest that: 1) the gastroprotective effect of clonidine is likely to be mediated by alpha-2B adrenoceptor subtype; 2) there is an interaction between pre-synaptic alpha-2 adrenoceptors and opioid system; and 3) clonidine can induce gastroprotection by central mechanism. (C) 2000 Elsevier Science Ltd. Published by Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:117 / 121
页数:5
相关论文
共 50 条
  • [21] INVOLVEMENT OF ALPHA-2 ADRENERGIC-RECEPTOR SUBTYPES IN HYPERGLYCEMIA
    ANGEL, I
    NIDDAM, R
    LANGER, SZ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1990, 254 (03): : 877 - 882
  • [22] Are alpha-2 adrenergic receptor polymorphisms associated with human hypertension?
    Li, JL
    Hollier, J
    Martin, DF
    Bell, D
    Leonard, D
    Auchus, RJ
    Victor, RG
    FASEB JOURNAL, 2005, 19 (05): : A1610 - A1610
  • [23] SPECIFICITY AND POTENCY OF GUANABENZ AT THE ALPHA-2 ADRENERGIC-RECEPTOR
    UNNERSTALL, JR
    KOPAJTIC, TA
    DEITCH, MW
    KUHAR, MJ
    FEDERATION PROCEEDINGS, 1982, 41 (05) : 1667 - 1667
  • [24] Alpha-2 adrenergic agonists
    Kamibayashi, T
    Harasawa, K
    Maze, M
    CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1997, 44 (05): : R13 - R18
  • [25] ALPHA-2 ADRENERGIC-RECEPTOR FUNCTION IN POSTSTROKE DEPRESSION
    BARRY, S
    DINAN, TG
    PSYCHOLOGICAL MEDICINE, 1990, 20 (02) : 305 - 309
  • [26] PHARMACOLOGICAL SPECIFICITY OF ALPHA-2 ADRENERGIC-RECEPTOR SUBTYPES
    PETRASH, A
    BYLUND, D
    FEDERATION PROCEEDINGS, 1986, 45 (03) : 563 - 563
  • [27] DESENSITIZATION OF ALPHA-ADRENERGIC RECEPTOR-MEDIATED VASOPRESSOR RESPONSE BY PHEOCHROMOCYTOMA
    TSUJIMOTO, G
    HONDA, K
    HASHIMOTO, K
    JAPANESE JOURNAL OF PHARMACOLOGY, 1986, 40 : P72 - P72
  • [28] Alpha-2 adrenergic agonistsLes agonistes alpha-2 adrénergiques
    Takahiko Kamibayashi
    Katsumi Harasawa
    Mervyn Maze
    Canadian Journal of Anaesthesia, 1997, 44 (Suppl 1) : R13 - R22
  • [29] Alpha-2 Adrenergic Receptor Homology Models using Rhodopsin or Beta-2 Adrenergic Receptor Templates
    Montgomery, Megan D.
    Bylund, David B.
    FASEB JOURNAL, 2009, 23
  • [30] FURTHER EVIDENCE FOR ALPHA-2 ADRENERGIC-RECEPTOR MEDIATED INHIBITION OF PROLACTIN SECRETION - EFFECT OF YOHIMBINE
    GOLD, MS
    DONABEDIAN, RK
    REDMOND, DE
    PSYCHONEUROENDOCRINOLOGY, 1978, 3 (3-4) : 253 - 260